Agilent Technologies, Inc. (A)

Agilent Technologies, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Agilent Technologies, Inc. (A) is a Medical - Diagnostics & Research company based in US with a market capitalization of $38.7B. Revenue grew 6.7% year-over-year and the company generated $1.2B in free cash flow. This page tracks A's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 17.9K employees · IPO Nov 18, 1999

Valuation

Valuation & price

$113.26 · as of May 15, 2026 · -28.0% vs 52w high

24.7

P/E ratio

Latest-FY diluted EPS

5.74

P/B ratio

Market cap ÷ book equity

Dividend yield

Price — last 12 months

$157$134$110Jul 25Dec 25Jul 26Jul 7, 25$119.25Jul 9, 25$121.30Jul 11, 25$123.28Jul 15, 25$112.94Jul 17, 25$116.36Jul 21, 25$112.04Jul 23, 25$119.47Jul 25, 25$120.18Jul 29, 25$119.84Jul 31, 25$114.81Aug 4, 25$114.84Aug 6, 25$113.23Aug 11, 25$114.13Aug 13, 25$120.29Aug 15, 25$119.20Aug 19, 25$120.11Aug 21, 25$117.15Aug 25, 25$119.15Aug 27, 25$118.69Aug 29, 25$125.66Sep 3, 25$125.22Sep 5, 25$128.75Sep 9, 25$126.25Sep 11, 25$126.73Sep 16, 25$127.19Sep 18, 25$127.62Sep 22, 25$126.33Sep 24, 25$124.38Sep 26, 25$123.39Sep 30, 25$128.35Oct 2, 25$138.70Oct 6, 25$141.61Oct 8, 25$140.81Oct 10, 25$136.62Oct 14, 25$138.04Oct 16, 25$141.10Oct 21, 25$145.68Oct 23, 25$147.46Oct 27, 25$146.59Oct 29, 25$143.20Oct 31, 25$146.36Nov 4, 25$146.08Nov 6, 25$147.49Nov 10, 25$146.36Nov 12, 25$151.52Nov 14, 25$146.82Nov 18, 25$143.84Nov 20, 25$145.06Nov 25, 25$157.20Nov 28, 25$153.50Dec 2, 25$148.81Dec 4, 25$148.32Dec 8, 25$142.44Dec 10, 25$143.47Dec 12, 25$139.68Dec 16, 25$139.19Dec 18, 25$136.90Dec 22, 25$138.52Dec 24, 25$138.32Dec 29, 25$137.93Jan 2, 26$137.95Jan 6, 26$147.60Jan 8, 26$145.76Jan 12, 26$147.99Jan 14, 26$145.92Jan 16, 26$139.64Jan 21, 26$139.77Jan 23, 26$135.05Jan 27, 26$135.95Jan 29, 26$133.27Feb 2, 26$135.39Feb 4, 26$132.98Feb 9, 26$127.50Feb 11, 26$128.90Feb 13, 26$125.81Feb 18, 26$126.94Feb 20, 26$122.90Feb 24, 26$124.40Feb 26, 26$120.97Mar 2, 26$118.17Mar 4, 26$120.54Mar 6, 26$115.07Mar 10, 26$115.43Mar 12, 26$111.63Mar 17, 26$112.75Mar 19, 26$111.75Mar 23, 26$112.02Mar 25, 26$112.98Mar 27, 26$110.24Mar 31, 26$113.98Apr 2, 26$115.48Apr 7, 26$113.88Apr 9, 26$115.39Apr 13, 26$117.50Apr 15, 26$119.77Apr 17, 26$121.87Apr 22, 26$120.47Apr 24, 26$115.55Apr 28, 26$114.87Apr 30, 26$115.55May 4, 26$112.18May 6, 26$117.69May 8, 26$115.62May 12, 26$112.90May 14, 26$113.26May 18, 26$112.11May 20, 26$113.78May 22, 26$114.96May 28, 26$135.38Jun 1, 26$135.98Jun 3, 26$137.40Jun 5, 26$135.44Jun 9, 26$135.48Jun 11, 26$129.55Jun 15, 26$130.59Jun 17, 26$124.33Jun 22, 26$126.49Jun 24, 26$131.63Jun 26, 26$136.01Jul 2, 26$130.69
$110.2452-week range$157.20
Loading valuation history…

Fundamentals

Key fundamentals

$38.7B

Market cap

6.7%

Revenue growth (YoY)

52.4%

Gross margin

$1.2B

Free cash flow (USD)

$1.6B

Net debt

-2.4%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

20162025

FY 2016$4.2BFY 2017$4.5BFY 2018$4.9BFY 2019$5.2BFY 2020$5.3BFY 2021$6.3BFY 2022$6.8BFY 2023$6.8BFY 2024$6.5BFY 2025$6.9B
$4.2B$6.9B

Free cash flow by year

20162025

FY 2016$654.0MFY 2017$713.0MFY 2018$910.0MFY 2019$865.0MFY 2020$802.0MFY 2021$1.3BFY 2022$1.0BFY 2023$1.5BFY 2024$1.4BFY 2025$1.2B
$654M$1.2B

Gross margin by year

20212025

FY 202153.9%FY 202254.4%FY 202350.7%FY 202454.3%FY 202552.4%
53.9%52.4%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last reported: May 27, 2026 (EPS $1.49)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventDebt IssuanceJun 25, 2026Filing
  • Insider sellInsider Sell $217KDolsten Mikael · Director · $216.7KJun 2, 2026Filing
  • Quarterly report10-Q FiledJun 1, 2026Filing
  • 8-K eventEarnings ReleaseMay 27, 2026Filing
  • 8-K eventCLO AppointmentMay 4, 2026Filing
  • 8-K eventTransition Agreement ExecutedApr 6, 2026Filing
  • 8-K eventExecutive Transition AgreementApr 3, 2026Filing

Questions

Frequently asked questions

What is Agilent Technologies, Inc.'s market cap?

Agilent Technologies, Inc. (A) has a market capitalization of $38.7B.

What is A's P/E ratio?

A trades at a price-to-earnings ratio of 24.7, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is A's price-to-book (P/B) ratio?

A trades at 5.74 times book value per share.

When did Agilent Technologies, Inc. last report earnings?

A last reported earnings on May 27, 2026; the next date is not yet scheduled.

Are insiders buying A stock?

SEC Form 4 filings show no open-market insider buys at Agilent Technologies, Inc. in the last 90 days (1 sell).

Same arena

Related companies in Medical - Diagnostics & Research

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.